N/A MLSs are private databases that are created, maintained and paid for by real estate professionals to help their clients buy and sell property.
Answer:
The answer is $229,200
Explanation:
Cost of sales equals:
Beginning inventory plus purchases minus ending inventory.
Beginning inventory is $23,570
Purchases(net Purchase) is
Purchases $224,020
Add: Freight-In. $9,770
Minus: Purchase Returns. and Allowances. ($5,460)
Net Purchase:. $228,330
ending inventory is $22,700.
Therefore, cost of goods sold is:
$23,570 + $228,330 - $22,700
=$229,200
Answer:
The appropriate solution is:
(a) 2828 cases each time
(b) $4005656.85
(c) $3609800
Explanation:
The given values are:
Annual demand,
D = 200,000 cases
Per case cost,
C = $20
Carrying host,
H = 
= $
Ordering cost,
S = $40
(a)
The economic order quantity will be:
⇒ 
On substituting the values, we get
![=\sqrt{[\frac{(2\times 200000\times 40)}{2} ]}](https://tex.z-dn.net/?f=%3D%5Csqrt%7B%5B%5Cfrac%7B%282%5Ctimes%20200000%5Ctimes%2040%29%7D%7B2%7D%20%5D%7D)
(b)
According to the question,
The annual ordering cost will be:
= 
= 
= 
($)
The annual carrying cost will be:
= 
= 
= 
($)
The annual purchase cost will be:
= 
= 
= 
($)
Now,
The total inventory cost will be:
= 
= 
($)
(c)
According to the question,
Order quantity,
Q = 10000 cases
Per case cost,
C = $18
Carrying cost,
H = 
= 
The annual ordering cost will be:
= 
= 
= 
($)
The annual carrying cost will be:
= 
= 
= 
($)
The annual purchase cost will be:
=
= 
= 
Now,
The total cost of inventory will be:
= 
= 
($)
Answer:
B) The stock price will not change, because the market had already incorporated the information about the FDA approval announcement in the stock price.
Explanation:
As explained in the question, the stock market consensus has been that even after the new drug was released, the stock price, and the earnings per share of the pharmaceutical company will remain the same, therefore, there will no volatility.
Explanation:
In that question, the answer is that a move to a product team structure would lead to greater efficiency or effectiveness would depend on the type of product or service the organization offers. Its structure must be developed so that its objectives and goals are more effectively achieved. In a functional structure, for example, which operates in the form of specific departments formed by people who use the same knowledge, tools or techniques to carry out a job, the product team's structure would not be as efficient and effective because all efforts of the divisions of a company with a functional structure are to offer the same product or service, through a system of systematized activities that integrate the organizational whole.
